Stocks Moving Premarket: Chip Stocks Rebound, Cleveland-Cliffs Jumps on a Q3 Beat and Disc Medicine Surges on Phase 3 Data
Chip stocks rebounded after the Nasdaq's worst week since April 2025, Cleveland-Cliffs jumped about 10% to 13% on a Q3 earnings beat and Disc Medicine surged on Phase 3 results. Plus the week-ahead calendar & what to watch.
U.S. stock futures were higher Monday, Oct. 19, as dip buyers returned to chip stocks after the Nasdaq's worst week since the April 2025 tariff turmoil, as reported by ZeroHedge. Cleveland-Cliffs is up on a third-quarter earnings beat, Disc Medicine is sharply higher on Phase 3 results, and CoreWeave and Intel are rising on analyst upgrades. Stocks trade normally today. All moves below are premarket and can change by the open.
Economic calendar: today and the coming week
The Fed is in its quiet period through Oct. 29, so no Fed officials are scheduled to speak this week, per HeyGoTrade. The next policy decision comes Oct. 27 to 28, with Q3 GDP and September PCE inflation due next week. ZeroHedge reported that traders see a low chance of an October rate hike, with the 10-year Treasury yield near 5.08% after its biggest weekly drop since August 2025. The sources did not give Eastern release times for most data, so only sourced times are shown.
| Day | Time | Event |
|---|---|---|
| Mon, Oct. 19 | All day | No major U.S. data sourced; stocks and bonds trade normally |
| Tue, Oct. 20 | Not sourced | Housing starts and building permits. Earnings: Netflix, GE Aerospace, GM, 3M and RTX |
| Wed, Oct. 21 | After the close | Earnings: Meta and Tesla |
| Thu, Oct. 22 | Not sourced | Weekly jobless claims, expected near 200,000 versus 199,000 prior. Earnings: Procter & Gamble before the open |
| Thu to Fri | Not sourced | S&P Global flash PMIs (manufacturing and services); day not specified |
| Fri, Oct. 23 | Not sourced | University of Michigan consumer sentiment |
Notable premarket moves
| Company | Ticker | Premarket | Why |
|---|---|---|---|
| Cleveland-Cliffs | CLF | +13% | Posted a third-quarter earnings beat. Other sources put the gain at over 10% |
| Disc Medicine | IRON | +26.7% | Phase 3 results. Price near $72.00 per Benzinga; another report cited a larger gain |
| CoreWeave | CRWV | +6% | Goldman Sachs upgraded the stock to Buy after a steep weekly drop |
| Silgan | SLGN | +5% | Agreed to buy Trivium Packaging |
| Intel | INTC | +3% to +4% | JPMorgan upgraded the stock to Neutral |
| Nvidia | NVDA | +1.4% | Chip stocks rebounded after a rough week |
| Amazon | AMZN | +1.2% | Broad tech rebound |
| Alphabet | GOOGL | +0.6% | Broad tech rebound |
Tesla and Apple were each about 0.1% lower premarket, per ZeroHedge. Only eight moves could be verified this morning, so the list is shorter than usual.
Analyst calls
Goldman Sachs upgraded CoreWeave to Buy, and JPMorgan upgraded Intel to Neutral. The sources did not list price targets.
Futures, yields and commodities
As of about 8:00 AM ET, S&P 500 futures were up 0.4% at 7,741.75 (Friday's close: 7,659), Nasdaq 100 futures were up 1.1% at 29,705.50 and Dow futures were down 0.2%, per ZeroHedge. The Philadelphia semiconductor index was set to snap an eight-day losing streak. Brent crude fell 1.2% to $108.59 and WTI was flat near $101.30. Energy Secretary Wright said Persian Gulf flows had recovered to about 80% of pre-conflict levels.
Readers also read
T-Mobile Plunges 13% as SpaceX's Reported $8 Billion Spectrum Deal Rattles AT&T and Verizon
ResearchMicron Is Stalling on Peak Fears, but Memory Prices Haven't Gotten the Memo
ResearchGoogle Gives Gemini Its Own Email Address and a Job: What the Workplace Agent Means for Alphabet Stock
RecapWeek Ahead: Fed Minutes, Five Fed Speakers and the First Big Earnings of Q3 Season
MarketCatalyst LLC is not a registered investment advisor and does not manage client assets. Content on this platform is provided for informational and educational purposes only. It is not investment advice, and MarketCatalyst is not a stock-picking or trade-alert service. Trading stocks and options involves risk, including the possible loss of principal. Consider your own goals, time horizon, and risk tolerance, and consult a qualified financial advisor before making any investment decision.